Skip to Main content Skip to Navigation
Journal articles

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value

Abstract : The recently described oncogene ZNF217 belongs to a chromosomal region that is frequently amplified in human cancers. Recent findings have revealed that alternative mechanisms such as epigenetic regulation also govern the expression of the encoded ZNF217 protein. Newly discovered molecular functions of ZNF217 indicate that it orchestrates complex intracellular circuits as a new key regulator of tumorigenesis. In this review, we focus on recent research on ZNF217-driven molecular functions in human cancers, revisiting major hallmarks of cancer and highlighting the downstream molecular targets and signaling pathways of ZNF217. We also discuss the exciting translational medicine investigating ZNF217 expression levels as a new powerful biomarker, and ZNF217 as a candidate target for future anti-cancer therapies.
Document type :
Journal articles
Complete list of metadata
Contributor : Hubert Lincet Connect in order to contact the contributor
Submitted on : Thursday, January 5, 2017 - 12:57:50 PM
Last modification on : Tuesday, October 19, 2021 - 11:07:42 PM
Long-term archiving on: : Thursday, April 6, 2017 - 1:22:01 PM


The dark side ZNF Oncotarget 2...
Files produced by the author(s)




Pascale A Cohen, Caterina F Donini, Nhan T Nguyen, Hubert F Lincet, Julie A Vendrell. The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value. Oncotarget, Impact journals, 2015, 6 (39), pp.41566-81. ⟨10.18632/oncotarget.5893⟩. ⟨inserm-01427161⟩



Record views


Files downloads